Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
Clinical trial NCT00231166 · COMPLETED
Trial details
- NCT number
- NCT00231166
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2009-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.